uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Bone Marrow Lymphocytic Status during Tyrosine Kinase Inhibitor Therapy and Its Relation to Therapy Response in Chronic Phase Chronic Myeloid Leukemia Patients
Univ Helsinki, Hematol Res Unit, Helsinki, Finland..
Univ Helsinki, Dept Hematol, HRUH, Helsinki, Finland.;Univ Helsinki, Cent Hosp, Ctr Comprehens Canc, Helsinki, Finland..
Univ Helsinki, Dept Hematol, Helsinki, Finland.;Univ Helsinki, Cent Hosp, Ctr Comprehens Canc, HRUH, Helsinki, Finland..
Univ Helsinki, Inst Clin Med, Helsinki, Finland..
Show others and affiliations
2015 (English)In: Blood, ISSN 0006-4971, E-ISSN 1528-0020, Vol. 126, no 23Article in journal, Meeting abstract (Other academic) Published
Resource type
Text
Place, publisher, year, edition, pages
2015. Vol. 126, no 23
National Category
Hematology
Identifiers
URN: urn:nbn:se:uu:diva-283000ISI: 000368021800284OAI: oai:DiVA.org:uu-283000DiVA: diva2:931388
Conference
55th Annual Meeting and Exposition of the American-Society-of-Hematology, DEC 07-10, 2013, New Orleans, LA
Available from: 2016-05-27 Created: 2016-04-08 Last updated: 2016-05-27Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Olsson-Strömberg, Ulla
By organisation
Haematology
In the same journal
Blood
Hematology

Search outside of DiVA

GoogleGoogle Scholar

Total: 221 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf